Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis
Hige, S., Ozeki, I., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Ohmura, T., Toyota, J., Karino, Y.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)31270-4
Date:
April, 2018
File:
PDF, 53 KB
english, 2018